This inventor holds 1 USPTO granted patent. Top assignee: Emerald Therapeutics, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Eric Shyr - Innovator in Nucleic Acid Preparation Technologies
Introduction
Eric Shyr is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of biotechnology, particularly in the automated preparation of nucleic acids. His innovative work has the potential to enhance various applications in genetic research and therapeutic development.
Latest Patents
Eric Shyr holds a patent for "Systems and methods for automated preparation of nucleic acids." This patent describes a fabrication process that produces, anneals, and conjugates nucleic acid molecules using multiple instruments under the guidance of computer programs. The process involves synthesizing nucleic acids and peptide nucleic acids on a solid support, measuring sample volumes and concentrations, and employing chromatography to achieve single-base resolution for the products. This innovative approach streamlines the preparation of biomolecules, making it more efficient and precise.
Career Highlights
Eric Shyr is currently associated with Emerald Therapeutics, Inc., where he continues to advance his research and development efforts. His work is instrumental in pushing the boundaries of nucleic acid technology, which is crucial for various scientific and medical applications.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including Brian M. Frezza and George W. Fraser. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their respective fields.
Conclusion
Eric Shyr's contributions to the field of nucleic acid preparation exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Emerald Therapeutics, Inc. highlight the importance of automation in scientific research.